ANTH / Anthera Pharmaceuticals, Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5

Anthera Pharmaceuticals, Inc.
US ˙ OTCPK ˙ US03674U3005

Deler fremragende 26,179,302 shares
Insideraktier1.781.700 shares
Insider ejerskab6,81 %
Total Insiders31
Insider-stemningsscore

Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.

Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.

Officers sentiment score

Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.

Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.

Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.

Nøgle Insider Metrics

Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.

For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).

Netto antal insidere, der køber (rang)

0 ( )
1023 out of 10963

Netto antal insidere, der køber, er det samlede antal insiders, der køber minus det samlede antal insiders, der har solgt inden for de sidste 90 dage. Percentilrangen vises her (spænder fra 0 til 100%).

Procent af float købt af insidere (rangering)

0.000% ( )
995 out of 10830

Procent af float købt af insidere er det samlede antal aktier købt af insidere minus det samlede antal aktier solgt af insidere inden for de sidste 90 dage, divideret med den samlede float og ganget med 100.

Insiderhandelsdiagram

Anthera Pharmaceuticals, Inc. insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.

Insiderliste og lønsomhedsmålinger

Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.

See our leaderboard of most profitable insider traders.

Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Eric Buatois 10% Owner - [10%] 44.969 5.621
Bogdan Dziurzynski Director - [D] 10.000 1.250
Klara Dickinson SVP & Chief Regulatory Office - [O] 12.500 1.562
Steven B Engle 41.379
Ursula Fritsch VP, Glob. Reg. and Compliance - [O] 55.592 6.949
Brent Furse 84.705
James Healy Director - [D] 32.443 4.055
Christopher S Henney Director - [D] 100.000 12.500
Colin Hislop Chief Medical Officer - [O] 19.147 2.393
Samuel D Isaly Director - [D] 7.462.000 932.750
Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Georgina Kilfoil SVP,Product Dev.& Project Mgmt - [O] 30.035 3.754
May Liu SVP, Finance & Administration - [O] 32.302 4.038
Lowe Christopher P. CFO and Chief Business Officer - [O] 108.915 13.614
Mark Drew McManigle 0
Brian Mueller Director - [D] 10.000 1.250
Debra Odink Chief Technology Officer - [O] 7.896 987
Orbimed Advisors Llc Director - [D] 7.462.000 932.750
Charles V Olson CHIEF TECHNOLOGY OFFICER - [O] 17.519 2.190
James E Pennington Chief Medical Officer & Ex. VP - [O] 105.140 13.142
James Pennington Interim Chief Medical Officer - [O] 35.376 4.422
Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
William R Jr Shanahan 567.876
Sofinnova Venture Partners Vi L P 10% Owner - [10%] 44.969 5.621
Daniel K Spiegelman 12.500
Philip Sager 84.705
John Craig Thompson President & CEO, Director - [D] [O] 19.848 19.848
Paul F Truex Director - [D] 16.793 16.793
Thompson David E. Director - [D] 128.201 16.025
Thompson Peter A. 12.000
Joaquim Trias SR VP, Preclinical Development - [O] 156.643 19.580
Sanford S Zweifach 28.846
Zenyaku Kogyo Co., Ltd. 10% Owner - [10%] 5.591.790 698.974

Report errors via our new Insider Auditing Tool

Track Records af insiderkøb - Kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ANTH / Anthera Pharmaceuticals, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2017-09-20 THOMPSON JOHN CRAIG 8.550 1,3200 8.550 1,3200 11.286 169 2.7 11.799 104,55
2017-09-07 THOMPSON JOHN CRAIG 10.400 1,4320 10.400 1,4320 14.893
2017-09-07 TRUEX PAUL F 5.000 1,3400 5.000 1,3400 6.700
2013-06-24 Thompson David E. 100.000 0,5300 12.500 4,2400 53.000
2013-05-31 DZIURZYNSKI BOGDAN 10.000 0,5900 1.250 4,7200 5.900
2013-01-30 ORBIMED ADVISORS LLC 5.700.000 0,6600 712.500 5,2800 3.762.000
2013-01-25 ORBIMED ADVISORS LLC 1.762.000 0,6484 220.250 5,1872 1.142.481
2012-06-29 TRUEX PAUL F 20.000 0,7600 2.500 6,0800 15.200
2012-06-29 HENNEY CHRISTOPHER S 100.000 0,7493 12.500 5,9944 74.930
2012-06-29 HENNEY CHRISTOPHER S 100.000 0,7493 12.500 5,9944 74.930

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

ANTH / Anthera Pharmaceuticals, Inc. Insider Trades
Track Records af insidersalg - Kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ANTH / Anthera Pharmaceuticals, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2015-11-11 Hislop Colin 5.000 5,3800 625 43,0400 26.900 365 1.9 -25.712 -95,59
2012-06-29 ORBIMED ADVISORS LLC 1.283.300 0,7341 160.412 5,8728 942.071
2012-03-22 ORBIMED ADVISORS LLC 1.306.700 2,4031 163.338 19,2248 3.140.131
2012-03-21 ORBIMED ADVISORS LLC 125.000 2,8665 15.625 22,9320 358.312
2012-03-20 ORBIMED ADVISORS LLC 116.800 2,8993 14.600 23,1944 338.638
2011-12-30 SOFINNOVA VENTURE PARTNERS VI L P 280 6,2250 35 49,8000 1.743
2011-12-30 SOFINNOVA VENTURE PARTNERS VI L P 4.090 6,2250 511 49,8000 25.460
2011-12-30 SOFINNOVA VENTURE PARTNERS VI L P 20.630 6,2250 2.579 49,8000 128.422

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

ANTH / Anthera Pharmaceuticals, Inc. Insider Trades
Transaktionshistorik

Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.

Fil
Dato
Handle
Dato
Form Insider Ticker Sikkerhedstitel Kode 10b5-1 Direkte Dyrke motion
Pris
Enhed
Pris
Enheder
Ændret
Værdi
Ændret (1K)
Tilbage
Muligheder
Tilbage
Aktier
2018-01-09 2018-01-05 4 HENNEY CHRISTOPHER S ANTH Stock Option (right to buy) A - Award D 1,65 84.705 84.705
2018-01-09 2018-01-05 4 HENNEY CHRISTOPHER S ANTH Stock Option (right to buy) A - Award D 1,65 84.705 84.705
2018-01-09 2018-01-05 4 Furse Brent ANTH Stock Option (right to buy) A - Award D 1,65 84.705 84.705
2018-01-09 2018-01-05 4 Furse Brent ANTH Stock Option (right to buy) A - Award D 1,65 84.705 84.705
2018-01-09 2018-01-05 4 Mueller Brian ANTH Stock Option (right to buy) A - Award D 1,65 84.705 84.705
2018-01-09 2018-01-05 4 Mueller Brian ANTH Stock Option (right to buy) A - Award D 1,65 84.705 84.705
2018-01-09 2018-01-05 4 Sager Philip ANTH Stock Option (right to buy) A - Award D 1,65 84.705 84.705
2018-01-09 2018-01-05 4 Sager Philip ANTH Stock Option (right to buy) A - Award D 1,65 84.705 84.705
2018-01-09 2018-01-05 4 Thompson David E. ANTH Stock Option (right to buy) A - Award D 1,65 84.705 84.705
2018-01-09 2018-01-05 4 Thompson David E. ANTH Stock Option (right to buy) A - Award D 1,65 84.705 84.705
2018-01-09 2018-01-05 4 TRUEX PAUL F ANTH Stock Option (right to buy) A - Award D 1,65 84.705 84.705
2018-01-09 2018-01-05 4 TRUEX PAUL F ANTH Stock Option (right to buy) A - Award D 1,65 84.705 84.705
2018-01-09 2018-01-05 4 LIU MAY ANTH Stock Option (right to buy) A - Award D 1,65 427.066 427.066
2018-01-09 2018-01-05 4 SHANAHAN WILLIAM R JR ANTH Stock Option (right to buy) A - Award D 1,65 567.876 567.876
2018-01-09 2018-01-05 4 THOMPSON JOHN CRAIG ANTH Stock Option (right to buy) A - Award D 1,65 1.847.074 1.847.074
2017-09-20 2017-09-20 4 THOMPSON JOHN CRAIG ANTH Common stock P - Purchase D 1,3200 8.550 11 19.848
2017-09-15 2017-09-15 4 LIU MAY ANTH Stock option (right to buy) J - Other D 24,16 -10.000 0
2017-09-15 2017-09-15 4 LIU MAY ANTH Stock option (right to buy) J - Other D 28,16 -10.000 0
2017-09-15 2017-09-15 4 LIU MAY ANTH Stock option (right to buy) J - Other D 22,88 -926 0
2017-09-15 2017-09-15 4 LIU MAY ANTH Stock option (right to buy) J - Other D 75,94 -3.750 0
2017-09-15 2017-09-15 4 LIU MAY ANTH Stock option (right to buy) J - Other D 75,84 -5.000 0
2017-09-15 2017-09-15 4 LIU MAY ANTH Stock option (right to buy) J - Other D 12,88 -15.000 0
2017-09-15 2017-09-15 4 LIU MAY ANTH Stock option (right to buy) J - Other D 26,40 -843 0
2017-09-15 2017-09-15 4 LIU MAY ANTH Stock option (right to buy) J - Other D 39,04 -10.938 0
2017-09-15 2017-09-15 4 LIU MAY ANTH Stock option (right to buy) J - Other D 96,64 -9 0
2017-09-15 2017-09-15 4 LIU MAY ANTH Stock Option (right to buy) J - Other D 96,64 -365 0
2017-09-07 2017-09-07 4/A THOMPSON JOHN CRAIG ANTH Common stock P - Purchase D 1,4320 10.400 15 11.298
2017-09-07 2017-09-07 4 TRUEX PAUL F By Trust ANTH Common Stock P - Purchase I 1,3400 5.000 7 16.793
2017-09-07 2017-09-07 4 THOMPSON JOHN CRAIG ANTH Common stock M - Exercise D 1,4320 10.400 15 17.590
2017-05-22 2017-05-20 4 Dickinson Klara ANTH Stock option (right to buy) A - Award D 1,63 43.750 43.750
2017-05-22 2017-05-20 4 LIU MAY ANTH Stock option (right to buy) A - Award D 1,63 53.125 53.125
2017-05-22 2017-05-20 4 THOMPSON JOHN CRAIG ANTH Stock option (right to buy) A - Award D 1,63 81.250 81.250
2017-05-22 2017-05-20 4 Olson Charles V ANTH Stock option (right to buy) A - Award D 1,63 43.750 43.750
2017-05-22 2017-05-20 4 SHANAHAN WILLIAM R JR ANTH Stock option (right to buy) A - Award D 1,63 75.000 75.000
2017-05-19 2017-05-19 4 TRUEX PAUL F ANTH Stock option (right to buy) J - Other D 39,04 -84.376 0
2017-05-19 2017-05-19 4 TRUEX PAUL F ANTH Stock option (right to buy) J - Other D 96,64 -1.369 0
2017-03-03 2016-12-06 4/A THOMPSON JOHN CRAIG ANTH Stock option (right to buy) A - Award D 1,47 200.000 200.000
2017-03-03 2017-03-03 4 THOMPSON JOHN CRAIG ANTH Stock option (right to buy) A - Award D 0,64 100.000 100.000
2017-02-06 2017-01-11 5 Olson Charles V ANTH Common Stock A - Award D 0,5500 7.767 4 17.519
2017-02-06 2016-06-30 5 Olson Charles V ANTH Common Stock A - Award D 2,6300 1.789 5 9.752
2017-02-06 2017-01-11 5 THOMPSON JOHN CRAIG ANTH Common Stock A - Award D 0,5500 7.190 4 7.190
2016-12-08 2016-12-08 4 HENNEY CHRISTOPHER S ANTH Stock Option (right to buy) A - Award D 2,00 83.910 83.910
2016-12-08 2016-12-08 4 Thompson David E. ANTH Stock Option (right to buy) A - Award D 2,00 83.910 83.910
2016-12-06 2016-12-02 4 TRUEX PAUL F ANTH Stock option (right to buy) J - Other D 9,48 -180.000 0
2016-12-06 2016-12-02 4 TRUEX PAUL F ANTH Stock option (right to buy) J - Other D 9,48 -170.000 0
2016-12-06 2016-12-06 4 THOMPSON JOHN CRAIG ANTH Stock option (right to buy) A - Award D 1,47 300.000 300.000
2016-09-22 2016-09-20 4 TRUEX PAUL F By Trust ANTH Common stock G - Gift I 5.008 94.345
2016-09-22 2016-09-20 4 TRUEX PAUL F ANTH Common stock G - Gift D -5.008 0
2016-09-22 2016-09-20 4 TRUEX PAUL F ANTH Common stock M - Exercise D 2,0800 5.008 10 5.008
2016-09-22 2007-01-23 4 TRUEX PAUL F ANTH Stock Option (right to buy) M - Exercise D 2,08 -5.008 25.845
2016-06-13 2016-06-09 4 TRUEX PAUL F ANTH Stock option (right to buy) A - Award D 3,52 300.000 300.000
2016-06-13 2016-06-09 4 Dickinson Klara ANTH Stock option (right to buy) A - Award D 3,52 105.000 105.000
2016-06-13 2016-06-09 4 THOMPSON JOHN CRAIG ANTH Stock option (right to buy) A - Award D 3,52 170.000 170.000
2016-06-13 2016-06-09 4 LIU MAY ANTH Stock option (right to buy) A - Award D 3,52 80.000 80.000
2016-06-13 2016-06-09 4 Olson Charles V ANTH Stock option (right to buy) A - Award D 3,52 100.000 100.000
2016-04-29 2016-04-27 4 ENGLE STEVEN B ANTH Stock Option (right to buy) A - Award D 3,80 41.379 41.379
2016-04-29 2016-04-27 4 HENNEY CHRISTOPHER S ANTH Stock Option (right to buy) A - Award D 3,80 62.069 62.069
2016-04-29 2016-04-27 4 Thompson David E. ANTH Stock Option (right to buy) A - Award D 3,80 41.379 41.379
2016-04-29 2016-04-27 4 Mueller Brian ANTH Stock Option (right to buy) A - Award D 3,80 41.379 41.379
2016-04-29 2016-04-27 4 Sager Philip ANTH Stock Option (right to buy) A - Award D 3,80 41.379 41.379
2016-04-05 3 Pennington James ANTH Common Stock D 35.376
2016-04-05 3 Pennington James ANTH Common Stock D 35.376
2016-02-16 2016-02-12 4 TRUEX PAUL F ANTH Stock option (right to buy) A - Award D 2,86 15.816 15.816
2016-02-16 2016-02-12 4 Hislop Colin ANTH Stock Option (right to buy) A - Award D 2,86 10.848 10.848
2016-02-16 2016-02-12 4 Dickinson Klara ANTH Stock Option (right to buy) A - Award D 2,86 8.395 8.395
2016-02-16 2016-02-12 4 LIU MAY ANTH Stock option (right to buy) A - Award D 2,86 7.407 7.407
2016-02-16 2016-02-12 4 Olson Charles V ANTH Stock option (right to buy) A - Award D 2,86 5.626 5.626
2016-01-13 3 Olson Charles V ANTH Common Stock D 15.926
2016-01-13 3 Olson Charles V ANTH Common Stock D 15.926
2016-01-11 2015-06-30 5 Dickinson Klara ANTH Common Stock A - Award D 1,4900 12.500 19 12.500
2015-12-24 2015-12-23 4 Mueller Brian ANTH Common stock M - Exercise D 2,8900 10.000 29 10.000
2015-12-24 2014-07-29 4 Mueller Brian ANTH Stock Option (right to buy) M - Exercise D 2,89 -10.000 2.500
2015-12-23 2015-06-30 5 LIU MAY ANTH Common Stock A - Award D 1,4900 12.500 19 32.302
2015-12-23 2015-06-30 5 TRUEX PAUL F By Trust ANTH Common Stock G - Gift I -12.500 89.337
2015-12-23 2015-06-30 5 TRUEX PAUL F By Trust ANTH Common Stock J - Other I 12.500 101.837
2015-12-23 2015-06-30 5 TRUEX PAUL F ANTH Common Stock J - Other D -12.500 0
2015-12-23 2015-06-30 5 TRUEX PAUL F ANTH Common Stock A - Award D 1,4900 12.500 19 12.500
2015-11-18 2015-11-13 4 Hislop Colin ANTH Common Stock S - Sale D 5,3073 -12.500 -66 19.147
2015-11-18 2015-11-13 4 Hislop Colin ANTH Common Stock M - Exercise D 1,6100 12.500 20 31.647
2015-11-18 2014-12-30 4 Hislop Colin ANTH Stock option M - Exercise D 1,61 -12.500 107.500
2015-11-12 2015-11-11 4 Hislop Colin ANTH Common Stock S - Sale D 5,3800 -5.000 -27 19.147
2015-10-13 2015-10-12 4 ODINK DEBRA ANTH Common Stock S - Sale D 6,1500 -1.205 -7 7.896
2015-09-18 2015-09-17 4 Dickinson Klara ANTH Stock option (right to buy) A - Award D 9,48 30.000 30.000
2015-09-18 2015-09-17 4 Dickinson Klara ANTH Stock option (right to buy) A - Award D 9,48 50.000 50.000
2015-09-18 2015-09-17 4 TRUEX PAUL F ANTH Stock option (right to buy) A - Award D 9,48 180.000 180.000
2015-09-18 2015-09-17 4 TRUEX PAUL F ANTH Stock option (right to buy) A - Award D 9,48 170.000 170.000
2015-09-18 2015-09-17 4 LIU MAY ANTH Stock option (right to buy) A - Award D 9,48 30.000 30.000
2015-09-18 2015-09-17 4 LIU MAY ANTH Stock option (right to buy) A - Award D 9,48 40.000 40.000
2015-09-18 2015-09-17 4 Hislop Colin ANTH Stock option (right to buy) A - Award D 9,48 30.000 30.000
2015-09-18 2015-09-17 4 Hislop Colin ANTH Stock option (right to buy) A - Award D 9,48 60.000 60.000
2015-09-18 2015-09-17 4 ODINK DEBRA ANTH Stock option (right to buy) A - Award D 9,48 30.000 30.000
2015-09-18 2015-09-17 4 ODINK DEBRA ANTH Stock option (right to buy) A - Award D 9,48 60.000 60.000
2015-05-22 2015-05-21 4 HENNEY CHRISTOPHER S ANTH Stock Option (right to buy) A - Award D 4,75 43.269 43.269
2015-05-22 2015-05-21 4 ZWEIFACH SANFORD S ANTH Stock Option (right to buy) A - Award D 4,75 28.846 28.846
2015-05-22 2015-05-21 4 ENGLE STEVEN B ANTH Stock Option (right to buy) A - Award D 4,75 28.846 28.846
2015-05-22 2015-05-21 4 Thompson David E. ANTH Stock Option (right to buy) A - Award D 4,75 28.846 28.846
2015-05-22 2015-05-21 4 Mueller Brian ANTH Stock Option (right to buy) A - Award D 4,75 28.846 28.846
2015-05-22 2015-05-21 4 Sager Philip ANTH Stock Option (right to buy) A - Award D 4,75 28.846 28.846
2015-02-03 3 Zenyaku Kogyo Co., Ltd. ANTH Common Stock D 5.591.790
2015-02-03 3 Zenyaku Kogyo Co., Ltd. ANTH Common Stock D 5.591.790
2015-01-02 2014-12-30 4 Sager Philip ANTH Stock Option (right to buy) A - Award D 1,61 15.000 12.500
2015-01-02 2014-12-30 4 Mueller Brian ANTH Stock Option (right to buy) A - Award D 1,61 12.500 12.500
2015-01-02 2014-12-30 4 Thompson David E. ANTH Stock Option (right to buy) A - Award D 1,61 12.500 12.500
2015-01-02 2014-12-30 4 Hislop Colin ANTH Stock option (right to buy) A - Award D 1,61 120.000 120.000
2015-01-02 2014-12-30 4 ODINK DEBRA ANTH Stock option (right to buy) A - Award D 1,61 120.000 120.000
2015-01-02 2014-12-30 4 ODINK DEBRA By The Debra A. Odink Living Trust ANTH Common Stock G - Gift I 1.364 13.855
2015-01-02 2014-12-30 4 ODINK DEBRA ANTH Common Stock G - Gift D -1.364 9.101
2015-01-02 2014-12-30 4 HENNEY CHRISTOPHER S ANTH Stock Option (right to buy) A - Award D 1,61 16.250 16.250
2015-01-02 2014-12-30 4 ENGLE STEVEN B ANTH Stock option (right to buy) A - Award D 1,61 12.500 12.500
2015-01-02 2014-12-30 4 ZWEIFACH SANFORD S ANTH Stock Option (right to buy) A - Award D 1,61 12.500 12.500
2015-01-02 2014-12-31 4 TRUEX PAUL F By Trust ANTH Common Stock G - Gift I 12.500 89.337
2015-01-02 2014-12-31 4 TRUEX PAUL F ANTH Common Stock G - Gift D -12.500 0
2015-01-02 2014-12-30 4 TRUEX PAUL F ANTH Stock option (right to buy) A - Award D 1,61 330.000 330.000
2015-01-02 2014-12-30 4 LIU MAY ANTH Stock option (right to buy) A - Award D 1,61 120.000 120.000
2014-08-04 2014-07-29 4 Mueller Brian ANTH Stock Option (right to buy) A - Award D 2,89 12.500 12.500
2014-08-04 2014-07-29 4 Mueller Brian ANTH Stock Option (right to buy) A - Award D 2,89 18.750 18.750
2014-07-01 2014-06-30 4 TRUEX PAUL F By Trust ANTH Common Stock J - Other I -14.709 14.709
2014-07-01 2014-06-30 4 TRUEX PAUL F By Trust ANTH Common Stock G - Gift I -16.500 62.128
2014-07-01 2014-06-30 4 TRUEX PAUL F ANTH Common Stock F - Taxes D 3,3900 -699 -2 14.709
2014-07-01 2014-06-30 4 TRUEX PAUL F ANTH Common Stock M - Exercise D 2,0800 2.000 4 13.845
2014-06-16 2014-06-13 4 ZWEIFACH SANFORD S ANTH Stock Option (right to buy) A - Award D 3,35 12.500 12.500
2014-06-16 2014-06-13 4 HENNEY CHRISTOPHER S ANTH Stock Option (right to buy) A - Award D 3,35 15.625 15.625
2014-06-16 2014-06-13 4 ENGLE STEVEN B ANTH Stock option (right to buy) A - Award D 3,35 12.500 12.500
2014-06-16 2014-06-13 4 ENGLE STEVEN B ANTH Stock option (right to buy) A - Award D 3,35 18.750 18.750
2014-06-16 2014-06-13 4 SPIEGELMAN DANIEL K ANTH Stock Option (right to buy) A - Award D 3,35 12.500 12.500
2014-06-16 2014-06-13 4 Thompson David E. ANTH Stock Option (right to buy) A - Award D 3,35 12.500 12.500
2014-06-16 2014-06-13 4 Sager Philip ANTH Stock Option (right to buy) A - Award D 3,35 12.500 31.250
2014-06-16 2014-06-13 4 Sager Philip ANTH Stock Option (right to buy) A - Award D 3,35 18.750 18.750
2014-03-28 2014-03-25 4/A TRUEX PAUL F ANTH Stock option (right to buy A - Award D 3,30 18.440 18.440
2014-03-28 2014-03-25 4/A TRUEX PAUL F ANTH Common Stock F - Taxes D 3,3000 -1.352 -4 11.845
2014-03-28 2014-03-25 4/A TRUEX PAUL F ANTH Common Stock A - Award D 3.864 13.197
2014-03-28 2014-03-25 4/A TRUEX PAUL F ANTH Common Stock F - Taxes D 3,3000 -7.622 -25 9.333
2014-03-28 2013-06-30 4/A TRUEX PAUL F By Trust ANTH Common Stock A - Award I 3,3000 6.250 21 80.190
2014-03-27 2014-03-25 4 TRUEX PAUL F ANTH Stock option (right to buy) A - Award D 3,30 18.440 18.440
2014-03-27 2014-03-25 4 TRUEX PAUL F By Trust ANTH Common Stock A - Award I 3,3000 6.250 21 597.787
2014-03-27 2014-03-25 4 TRUEX PAUL F ANTH Common Stock A - Award D 3.864 13.197
2014-03-27 2014-03-25 4 TRUEX PAUL F ANTH Common Stock F - Taxes D 3,3000 -7.622 -25 9.333
2014-03-27 2014-03-25 4 ODINK DEBRA ANTH Stock option (right to buy) A - Award D 3,30 10.070 10.070
2014-03-27 2014-03-25 4 ODINK DEBRA ANTH Common Stock A - Award D -3.864 10.465
2014-03-27 2014-03-25 4 ODINK DEBRA ANTH Common Stock F - Taxes D 3,3000 -2.783 -9 6.601
2014-03-27 2014-03-25 4 Hislop Colin ANTH Stock option (right to buy) A - Award D 3,30 12.871 12.871
2014-03-27 2014-03-25 4 Hislop Colin ANTH Common Stock A - Award D 3.864 24.147
2014-03-27 2014-03-25 4 Hislop Colin ANTH Common Stock F - Taxes D -3.323 20.283
2014-03-27 2014-03-25 4 LIU MAY ANTH Stock Option (right to buy) A - Award D 3,30 6.745 6.745
2014-03-27 2014-03-25 4 LIU MAY ANTH Common Stock A - Award D -3.625 7.302
2014-03-27 2014-03-25 4 LIU MAY ANTH Common Stock F - Taxes D 3,3000 -529 -2 3.677
2013-12-18 2013-12-16 4 LIU MAY ANTH Stock Option (right to buy) A - Award D 3,02 80.000 170.494
2013-07-02 2013-06-30 4 ODINK DEBRA ANTH Common Stock F - Taxes D 0,4900 -2.248 -1 75.074
2013-07-02 2013-06-30 4 LIU MAY ANTH Common Stock F - Taxes D 0,4900 -675 -0 33.655
2013-06-26 2013-06-24 4 Thompson David E. By David E. Thompson Revocable Trust ANTH Common Stock P - Purchase I 0,5300 100.000 53 128.201
2013-06-04 2013-05-31 4 DZIURZYNSKI BOGDAN ANTH Common Stock P - Purchase D 0,5900 10.000 6 10.000
2013-05-28 3 LIU MAY ANTH Common Stock D 34.330
2013-05-21 2013-05-17 4 Hislop Colin ANTH Stock option (right to buy) A - Award D 0,61 1.300.000 1.300.000
2013-05-21 2013-05-17 4 ODINK DEBRA ANTH Stock option (right to buy) A - Award D 0,61 1.400.000 1.400.000
2013-05-21 2013-05-21 4 TRUEX PAUL F By Trust ANTH Common Stock G - Gift I -100.000 591.537
2013-05-21 2013-05-17 4 TRUEX PAUL F ANTH Stock option (right to buy) A - Award D 0,61 5.400.000 5.400.000
2013-05-21 2013-05-17 4 LOWE CHRISTOPHER P. ANTH Stock option (right to buy) A - Award D 0,61 1.300.000 1.300.000
2013-05-20 2013-05-17 4 DZIURZYNSKI BOGDAN ANTH Stock Option (right to buy) A - Award D 0,61 100.000 100.000
2013-05-20 2013-05-17 4 SPIEGELMAN DANIEL K ANTH Stock Option (right to buy) A - Award D 0,61 100.000 100.000
2013-05-20 2013-05-17 4 ZWEIFACH SANFORD S ANTH Stock Option (right to buy) A - Award D 0,61 150.000 150.000
2013-05-20 2013-05-17 4 ZWEIFACH SANFORD S ANTH Stock Option (right to buy) A - Award D 0,61 100.000 100.000
2013-05-20 2013-05-17 4 HEALY JAMES ANTH Stock Option (right to buy) A - Award D 0,61 100.000 100.000
2013-05-20 2013-05-17 4 HENNEY CHRISTOPHER S ANTH Stock Option (right to buy) A - Award D 0,61 125.000 125.000
2013-05-20 2013-05-17 4 Thompson David E. ANTH Stock Option (right to buy) A - Award D 0,61 100.000 100.000
2013-05-20 2013-05-17 4 Thompson David E. ANTH Stock Option (right to buy) A - Award D 0,61 100.000 100.000
2013-03-27 2013-03-25 4 Hislop Colin ANTH Common Stock A - Award D 59.132 144.091
2013-03-27 2013-03-25 4 ODINK DEBRA ANTH Common Stock A - Award D 49.519 77.322
2013-03-27 2013-03-25 4 TRUEX PAUL F ANTH Common Stock A - Award D 135.644 135.644
2013-03-27 2013-03-25 4 LOWE CHRISTOPHER P. ANTH Common Stock A - Award D 67.579 108.915
2013-02-01 2013-01-30 4 ORBIMED ADVISORS LLC See Footnotes ANTH Common Stock P - Purchase I 0,6600 5.700.000 3.762 7.462.000
2013-01-29 2013-01-25 4 ORBIMED ADVISORS LLC See Footnotes ANTH Common Stock P - Purchase I 0,6484 1.762.000 1.142 1.762.000
2013-01-11 2013-01-10 4 ODINK DEBRA By The Debra A. Odink Living Trust ANTH Common Stock G - Gift I 4.009 99.937
2013-01-11 2013-01-10 4 ODINK DEBRA ANTH Common Stock G - Gift D -4.009 27.803
2013-01-08 2013-01-07 4 TRUEX PAUL F By Trust ANTH Common stock G - Gift I 66.412 691.537
2013-01-08 2013-01-07 4 TRUEX PAUL F ANTH Common Stock G - Gift D -66.412 0
2013-01-08 2013-01-03 4 TRUEX PAUL F ANTH Common Stock F - Taxes D 0,6900 -17.454 -12 66.412
2013-01-07 2013-01-03 4 KILFOIL GEORGINA ANTH Common Stock F - Taxes D 0,6900 -2.410 -2 30.035
2013-01-07 2013-01-03 4 Hislop Colin ANTH Common Stock F - Taxes D 0,6900 -4.560 -3 84.959
2013-01-07 2013-01-03 4 ODINK DEBRA ANTH Common Stock F - Taxes D 0,6900 -3.409 -2 31.812
2013-01-07 2013-01-03 4 LOWE CHRISTOPHER P. ANTH Common stock F - Taxes D 0,6900 -8.660 -6 41.336
2012-07-03 2012-06-30 4 ODINK DEBRA ANTH Common Stock F - Taxes D 0,6900 -1.838 -1 24.821
2012-07-03 2012-06-30 4 KILFOIL GEORGINA ANTH Common Stock F - Taxes D 0,6900 -2.068 -1 24.601
2012-07-03 2012-06-29 4 ORBIMED ADVISORS LLC See Footnotes ANTH Common Stock S - Sale I 0,7341 -1.283.300 -942 0
2012-07-02 2012-06-29 4 TRUEX PAUL F By Trust ANTH Common stock P - Purchase I 0,7600 20.000 15 645.125
2012-07-02 2012-06-29 4 HENNEY CHRISTOPHER S By Christopher Scot Henney TTEE Henney QPRT Maui Trust ANTH Common Stock P - Purchase I 0,7493 100.000 75 100.000
2012-07-02 2012-06-29 4 HENNEY CHRISTOPHER S ANTH Common Stock P - Purchase D 0,7493 100.000 75 100.000
2012-05-10 2012-05-08 4 HENNEY CHRISTOPHER S ANTH Stock Option (right to buy) A - Award D 1,79 15.000 15.000
2012-05-10 2012-05-08 4 DZIURZYNSKI BOGDAN ANTH Stock Option (right to buy) A - Award D 1,79 12.000 12.000
2012-05-10 2012-05-08 4 HEALY JAMES ANTH Stock Option (right to buy) A - Award D 1,79 12.000 12.000
2012-05-10 2012-05-08 4 SPIEGELMAN DANIEL K ANTH Stock Option (right to buy) A - Award D 1,79 12.000 12.000
2012-05-10 2012-05-08 4 Thompson Peter A. ANTH Stock Option (right to buy) A - Award D 1,79 12.000 12.000
2012-05-10 2012-05-08 4 Thompson David E. ANTH Stock Option (right to buy) A - Award D 1,79 12.000 12.000
2012-04-03 2012-03-30 4 Hislop Colin ANTH Stock Option (right to buy) A - Award D 2,21 80.000 80.000
2012-04-03 2012-03-30 4 ODINK DEBRA ANTH Stock Option (right to buy) A - Award D 2,21 160.000 160.000
2012-04-03 2012-03-30 4 KILFOIL GEORGINA ANTH Stock Option (right to buy) A - Award D 2,21 60.000 60.000
2012-04-03 2012-03-30 4 DZIURZYNSKI BOGDAN ANTH Stock Option (right to buy) A - Award D 2,21 25.000 25.000
2012-04-03 2012-03-30 4 TRUEX PAUL F ANTH Stock Option (right to buy) A - Award D 2,21 175.000 175.000
2012-04-03 2012-03-30 4 LOWE CHRISTOPHER P. ANTH Stock Option (right to buy) A - Award D 2,21 80.000 80.000
2012-03-22 2012-03-22 4 ORBIMED ADVISORS LLC See Footnotes ANTH Common Stock S - Sale I 2,4031 -1.306.700 -3.140 1.283.300
2012-03-22 2012-03-21 4 ORBIMED ADVISORS LLC See Footnotes ANTH Common Stock S - Sale I 2,8665 -125.000 -358 2.590.000
2012-03-22 2012-03-20 4 ORBIMED ADVISORS LLC See Footnotes ANTH Common Stock S - Sale I 2,8993 -116.800 -339 2.715.000
2012-03-05 2012-03-01 4 ODINK DEBRA ANTH Common Stock S - Sale D 6,5700 -2.000 -13 26.659
2012-02-27 2012-02-23 4 Hislop Colin ANTH Stock Option M - Exercise D 0,26 -40.000 50.447
2012-02-27 2012-02-23 4 Hislop Colin ANTH Common Stock M - Exercise D 0,2600 40.000 10 79.519
2012-02-17 2012-02-15 4 TRUEX PAUL F By Trust ANTH Common stock S - Sale I 7,8400 -15.000 -118 625.125
2012-02-07 2012-02-06 4 KILFOIL GEORGINA ANTH Common Stock A - Award D 5.243 24.513
2012-02-06 2012-02-06 4 Hislop Colin ANTH Common Stock A - Award D 9.923 39.519
2012-02-06 2012-02-03 4 Hislop Colin ANTH Common Stock S - Sale D 8,2000 -30.000 -246 27.967
2012-02-06 2012-02-06 4 TRUEX PAUL F ANTH Common stock A - Award D 37.984 79.755
2012-02-06 2012-02-06 4 ODINK DEBRA ANTH Common Stock A - Award D 7.418 28.659
2012-02-06 2012-02-06 4 LOWE CHRISTOPHER P. ANTH Common Stock A - Award D 18.845 49.996
2012-02-03 2012-02-01 4 ODINK DEBRA ANTH Common Stock S - Sale D 7,6700 -2.000 -15 21.241
2012-02-03 2012-02-01 4 LOWE CHRISTOPHER P. ANTH Common stock S - Sale D 7,6600 -15.000 -115 31.151
2012-02-02 2012-01-31 4 TRUEX PAUL F By Trust ANTH Common stock M - Exercise I 0,2600 20.000 5 640.125
2012-02-02 2012-01-27 4 TRUEX PAUL F By Trust ANTH Common stock G - Gift I -7.000 620.125
2012-02-02 2011-01-31 4 TRUEX PAUL F ANTH Stock Option (right to buy) M - Exercise D 0,26 -20.000 262.826
2012-01-31 2012-01-28 4 HEALY JAMES ANTH Stock Option (right to buy) M - Exercise D 4,19 -12.000 0
2012-01-31 2012-01-28 4 HEALY JAMES ANTH Common Stock M - Exercise D 4,1900 -12.000 -50 32.443
2012-01-19 2012-01-17 4 TRUEX PAUL F By Trust ANTH Common stock S - Sale I 6,7500 -15.000 -101 627.125
2012-01-12 2012-01-10 4 ODINK DEBRA ANTH Common Stock S - Sale D 6,5066 -800 -5 23.241
2012-01-10 2012-01-06 4 ODINK DEBRA ANTH Common Stock S - Sale D 6,5000 -1.200 -8 24.441
2012-01-03 2011-12-30 4 HEALY JAMES See footnote. ANTH Common Stock S - Sale I 6,2250 -280 -2 44.969
2012-01-03 2011-12-30 4 HEALY JAMES See footnote. ANTH Common Stock S - Sale I 6,2250 -4.090 -25 653.550
2012-01-03 2011-12-30 4 HEALY JAMES See footnote. ANTH Common Stock S - Sale I 6,2250 -20.630 -128 3.298.684
2012-01-03 2011-12-30 4 SOFINNOVA VENTURE PARTNERS VI L P ANTH Common Stock S - Sale D 6,2250 -280 -2 44.969
2012-01-03 2011-12-30 4 SOFINNOVA VENTURE PARTNERS VI L P ANTH Common Stock S - Sale D 6,2250 -4.090 -25 653.550
2012-01-03 2011-12-30 4 SOFINNOVA VENTURE PARTNERS VI L P ANTH Common Stock S - Sale D 6,2250 -20.630 -128 3.298.684
2010-03-26 3 KILFOIL GEORGINA By husband ANTH Common Stock I 70.093
2010-02-23 3 PENNINGTON JAMES E ANTH Common Stock D 105.140
2010-02-23 3 ODINK DEBRA By The Debra A. Odink Living Trust ANTH Common Stock I 78.405
2010-02-23 3 Hislop Colin ANTH Common Stock D 5.841
2010-02-23 3 Thompson David E. ANTH Common Stock D 20.443
2010-02-23 3 HENNEY CHRISTOPHER S ANTH Common Stock D 14.602
2010-02-23 3 Trias Joaquim ANTH Common Stock D 156.643
2010-02-23 3 TRUEX PAUL F ANTH Common Stock D 662.967
2010-02-23 3 Fritsch Ursula ANTH Common Stock D 55.592
2010-02-23 3 HEALY JAMES ANTH Common Stock D 20.443
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista